News
SpeeDx receives FDA listing for Mycoplasma genitalium product
SpeeDx’s ResistancePlus® MG Positive Control kit has now been listed with the US Food and Drug Administration (FDA) for sale …
Continue ReadingUpdated guidelines for M. genitalium recommend resistance testing
The Australian STI management guidelines have been updated and now suggest when testing for Mycoplasma genitalium that inclusion of macrolide …
Continue ReadingTGA approval for SpeeDx PlexPCR® VHS | HSV-1&2, VZV & TP |
SpeeDx Multiplexed VZV, Herpes, Syphilis Assay is now fully registered as an IVD in the Australian market. The single-well test …
Continue ReadingNew test developed for virulent STI
You may have never heard of it, but Mycoplasma genitalium – MG for short – is one of the most …
Continue ReadingMycoplasma genitalium is thought to affect about 400,000 Australians…
…but many people have never heard of it. The bacterium can cause painful urination, itching and bleeding in the rectum, …
Continue ReadingAustralian-made test makes doctor’s and patient’s life “a whole lot easier”
Mycoplasma genitalium is a little-known sexually transmitted infection affecting up to two per cent of the population. A new test …
Continue ReadingAussie ‘Nobel’ spotlights SpeeDx war on superbug
Cicada Innovations, a “super incubator”, and headquarters for the SpeeDx office, manufacturing and production facilities, have created an event to …
Continue ReadingSpeeDx Pty. Ltd. establishes US-based operation
SpeeDx Pty. Ltd. announced the incorporation of a US-based subsidiary company, SpeeDx Inc. The US base will support current clinical …
Continue ReadingAntibiotic-resistant Mycoplasma genitalium may soon be as great a health risk as chlamydia
According to health professionals, Mycoplasma genitalium is developing resistance to antibiotics at an alarming rate. Much like chlamydia, many people …
Continue ReadingSpeeDx is transforming global health outcomes
SpeeDx has significantly contributed to the success and development of the Australian MedTech industry. The CSIRO’s Medical Technologies and Pharmaceutical …
Continue Reading